| Literature DB >> 35682931 |
Josef Jampilek1,2, Katarina Kralova3.
Abstract
Climate change and increasing contamination of the environment, due to anthropogenic activities, are accompanied with a growing negative impact on human life. Nowadays, humanity is threatened by the increasing incidence of difficult-to-treat cancer and various infectious diseases caused by resistant pathogens, but, on the other hand, ensuring sufficient safe food for balanced human nutrition is threatened by a growing infestation of agriculturally important plants, by various pathogens or by the deteriorating condition of agricultural land. One way to deal with all these undesirable facts is to try to develop technologies and sophisticated materials that could help overcome these negative effects/gloomy prospects. One possibility is to try to use nanotechnology and, within this broad field, to focus also on the study of two-dimensional carbon-based nanomaterials, which have excellent prospects to be used in various economic sectors. In this brief up-to-date overview, attention is paid to recent applications of graphene-based nanomaterials, i.e., graphene, graphene quantum dots, graphene oxide, graphene oxide quantum dots, and reduced graphene oxide. These materials and their various modifications and combinations with other compounds are discussed, regarding their biomedical and agro-ecological applications, i.e., as materials investigated for their antineoplastic and anti-invasive effects, for their effects against various plant pathogens, and as carriers of bioactive agents (drugs, pesticides, fertilizers) as well as materials suitable to be used in theranostics. The negative effects of graphene-based nanomaterials on living organisms, including their mode of action, are analyzed as well.Entities:
Keywords: agrochemicals; drugs; graphene; graphene oxide; graphene oxide quantum dots; graphene quantum dots; nanocarriers; reduced graphene oxide
Mesh:
Substances:
Year: 2022 PMID: 35682931 PMCID: PMC9181547 DOI: 10.3390/ijms23116253
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Potential biomedical applications of two-dimensional graphene-based nanomaterials. Adapted from [17], copyright 2022, MDPI.
Figure 2Structural overview of graphene-based materials. Adapted from [62], copyright 2021, MDPI.
Figure 3Differential charge density of different molecular graphene surfaces. (a) G-DOX; (b) GO-OH-DOX; (c) GO-O-DOX; (d) GO-OH-O-DOX. The yellow and blue areas represent an increase and decrease in charge density, respectively. Adapted from [63], copyright 2022, MDPI.
Figure 4Illustration of cellular uptake and drug release of DOX-loaded dual stimuli-responsive degradable GRQDs, in HER2-positive breast cancer cells. Adapted from [103], copyright 2020, MDPI.
Effects of selected graphene-based nanomaterials on treatment of cancer, infectious diseases, and other diseases.
| Nanocomposites | Effects | Refs. |
|---|---|---|
| GO | toxicity to MDA-MB-231 cells | [ |
| GO | inhibition of | [ |
| GO | inhibition of | [ |
| GO | protection of A549 and TC28a2 cells against Rubella virus infection | [ |
| GO | antiangiogenic effect in primary human endothelial Huvec cells | [ |
| COOH-CO–99mTc | imaging agent | [ |
| Pluronic–COOH-GO–ZnO | toxicity to U87MG and U138MG cells | [ |
| PEG–GO + NIR irradiation | growth inhibition of HT29 cells (wound closure ability) | [ |
| GO, PCA–CA–GO, PCA–CA–FA–GO | inhibition cell cycle at G | [ |
| benzofurazans modified GO | inhibition of biofilm formation ( | [ |
| functionalized (poly- | activation of cellular and humoral immunity | [ |
| Ag−GO | kills | [ |
| Cu−GO | inhibition of | [ |
| Au–GO | antioxidative activity | [ |
| TiO2–GO + NIR irradiation | inhibition of | [ |
| polyaniline–MnOx–GOQDs + irradiation (365 nm) | antimicrobial activity to | [ |
| PEG–GO loaded with anticancer drugs | controlled release of drugs and bioimaging | [ |
| FA–GO loaded with Pt anticancer drugs | ↑ cumulative release rate of drugsinhibition SKOV3 cells | [ |
| FA–GO loaded with raloxifene | pH-dependent drug release | [ |
| mannose–CS–GO loaded with ulvan | pH-dependent-controlled release and targeted delivery to U87 cells | [ |
| Pluronic−GO loaded with DOX | apoptosis of U251 cells | [ |
| Au@Ag–Fe3O4–GO loaded with DOX | covalent binding to anti-HER2 antibody | [ |
| Fe3O4@PEG–GO loaded with DOX | pH-dependent drug release | [ |
| PVP–Fe3O4–GO loaded with quercetin | pH-dependent drug release | [ |
| β-cyclodextrin–cholic acid–hyaluronic acid–Fe3O4–GO loaded with camptothecin | multiple targeting (hepatic, CD44-receptor) | [ |
| SPION–PCL/CS–GO loaded with 5-FU + magnetic field | ↑ tumor site temperature | [ |
| γ-Fe2O3–GO–MitP loaded with MTX | release of drug | [ |
| citric acid–CS–TEPA–rGO | inhibition of biofilm formation ( | [ |
| Ag–rGO | photoantimicrobial activities | [ |
| Zn–hydroxyapatite–rGO | ↑ antibacterial activity | [ |
| ZnO–rGO | enhanced catechin release at acidic pH | [ |
| FA–Au–rGO +NIR irradiation | improved generation of 1O2 | [ |
| arabinoxylan–CS–rGO loaded with sulfadiazine | controlled release of drug | [ |
| Pluronic–rGO loaded with buprenorphine | prolonged release of drug (treatment of chronic pain in osteoarthritis) | [ |
| Pluronic–rGO loaded with lidocaine | prolonged release of drug (prolonged effects of local anesthesia) | [ |
Figure 5Applications of reduced graphene oxide in therapy of cancer. Adapted from [163], copyright 2021, MDPI.
Effects of two-dimensional graphene-based nanomaterials on harmful insects.
| GBNs | Insect | Dose of GBNs | Effects | Refs. |
|---|---|---|---|---|
| GRQDs−cysteine protease from seeds of | 7 mg/g | ↓ number of eggs and larvae | [ | |
| GO |
| 500, 1000, 2000 μg/g | ↑ larval and pupal weights | [ |
| GO-cyhalothrin | 37.5–300 μg/mL | ↑ activity of pesticides (based on IC50 values) temperature-responsive release | [ | |
| GO | >25 mg/L | ↑ oxidative stress, ROS, DNA damage | [ | |
| GO |
| 1000 μg/g of diet d.m. | ↓ fecundity and fertility | [ |
| GO+β-cyfluthrin |
| 12.5–100 μg/mL | ↑ mortality | [ |
Effects of two-dimensional graphene-based nanomaterials on plants.
| GNMs | Plant (Cultivation Medium) | Dose of GNMs | Effects | Refs. |
|---|---|---|---|---|
| GO, rGO, GOQDs | 0.25–25 mg/kg | [ | ||
| GO | 10 mg/L | [ | ||
| glycine betaine−GO | 50, 100 mg/L | [ | ||
| COOH−GQDsOH−GQDs | 50 mg/L | [ | ||
| GO | 200–800 mg/L | [ | ||
| GO | 100, 250 mg/L | [ | ||
| Ag−GO | 0.2–1.6 g/L | [ | ||
| GO | 400 mg/L | [ | ||
| proline-GO | 50,100 mg/L | [ | ||
| GO | 30 mg/L | [ | ||
| GO | Cd-stressed | 30 mg/L | [ | |
| GO | 1.5, 3 μg/L | [ | ||
| GR | 10–1000 mg/L | [ | ||
| GO | 800 g/L | [ | ||
| GO | 300 mg/L | [ | ||
| GO | Cd-stressed | 100 mg/L | [ | |
| GO | Cd-stressed | 5 mg/L | [ | |
| AgNPs-GR | 40 mM | [ | ||
| GR | 10–100 mg/L | [ | ||
| GR | 50 mg/L | [ | ||
| GO | 50, 100 mg/L | [ | ||
| GQDs | 250–1250 mg/L | [ |